CN108244442A - 魔芋薤白固体饮料及制备方法 - Google Patents
魔芋薤白固体饮料及制备方法 Download PDFInfo
- Publication number
- CN108244442A CN108244442A CN201711496341.2A CN201711496341A CN108244442A CN 108244442 A CN108244442 A CN 108244442A CN 201711496341 A CN201711496341 A CN 201711496341A CN 108244442 A CN108244442 A CN 108244442A
- Authority
- CN
- China
- Prior art keywords
- parts
- konjaku
- powder
- onion bulb
- longstamen onion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000304531 Allium macrostemon Species 0.000 title claims abstract description 31
- 229920002752 Konjac Polymers 0.000 title claims abstract description 31
- 235000013361 beverage Nutrition 0.000 title claims abstract description 26
- 239000007787 solid Substances 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 25
- 239000011812 mixed powder Substances 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 9
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 8
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 8
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 8
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 8
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 8
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 8
- 240000000249 Morus alba Species 0.000 claims abstract description 8
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 8
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims abstract description 8
- 235000013312 flour Nutrition 0.000 claims abstract description 8
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 8
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 7
- 239000002245 particle Substances 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000005733 Raphanus sativus var niger Nutrition 0.000 claims abstract description 6
- 239000000706 filtrate Substances 0.000 claims abstract description 6
- CAXNYFPECZCGFK-UHFFFAOYSA-N 2-phenyl-2-pyridin-2-ylacetonitrile Chemical compound C=1C=CC=NC=1C(C#N)C1=CC=CC=C1 CAXNYFPECZCGFK-UHFFFAOYSA-N 0.000 claims abstract description 4
- 238000001914 filtration Methods 0.000 claims abstract description 3
- 244000088415 Raphanus sativus Species 0.000 claims abstract 3
- 239000000463 material Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 101710094902 Legumin Proteins 0.000 claims description 4
- NEKNNCABDXGBEN-UHFFFAOYSA-L disodium;4-(4-chloro-2-methylphenoxy)butanoate;4-(2,4-dichlorophenoxy)butanoate Chemical compound [Na+].[Na+].CC1=CC(Cl)=CC=C1OCCCC([O-])=O.[O-]C(=O)CCCOC1=CC=C(Cl)C=C1Cl NEKNNCABDXGBEN-UHFFFAOYSA-L 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 235000013339 cereals Nutrition 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 abstract description 19
- 230000036541 health Effects 0.000 abstract description 7
- 206010028980 Neoplasm Diseases 0.000 abstract description 6
- 208000008589 Obesity Diseases 0.000 abstract description 2
- 230000002950 deficient Effects 0.000 abstract description 2
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 2
- 235000020824 obesity Nutrition 0.000 abstract description 2
- 239000002253 acid Substances 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 241000220259 Raphanus Species 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000001889 Acid-Base Imbalance Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011973 solid acid Substances 0.000 description 1
- -1 solid acid object Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种魔芋薤白固体饮料及制备方法，包括如下步骤：(1)称取下述原料：薤白、桑椹、山药和莱菔子；(2)分别向各个原料中加入水，煎煮，滤过，合并滤液，浓缩，分别喷雾干燥成细粉；(3)将步骤(2)获得的细粉混合后按质量取10份，与魔芋粉3‑5份、蛹虫草粉5‑10份和大豆蛋白粉5‑10份混合得混合粉，加入混合粉质量55％‑65％的麦芽糊精，混合均匀，加入食用酒精做成颗粒，为魔芋薤白固体饮料。本发明的固体饮料不含糖，扩大了服用人群，糖尿病、肥胖等禁糖人群可以放心服用。本发明魔芋薤白固体饮料能调节人体酸碱失衡和阴阳失衡等亚健康状态，适用于酸性体质、亚健康、体质虚损，有肿瘤家族病史的人群。
Description
技术领域
本发明属于食品领域，涉及一种具有能调节人体酸碱失衡和阴阳失衡等亚健康状态作用的魔芋薤白固体饮料及制备方法。
背景技术
正常人血液的pH值在7.35-7.45之间，为碱性体质者，但这部分人只占总人群的10％左右，更多人的体液的pH值在7.35以下，身体处于健康和疾病之间的亚健康状态，医学上称为酸性体质者。与碱性体质者相比，酸性体质者常会感到身体疲乏、记忆力衰退、注意力不集中、腰酸腿痛，到医院检查又查不出什么毛病，如不注意改善，就会继续发展成疾病。
随着人们生活水平的提高，动物性食品和蛋类等酸性食物消耗量大幅度上升，这些酸性食物在体内代谢后产生乳酸、尿素等酸性产物。因此，长期过量摄入酸性食物或摄入碱性食物过少，使酸性代谢产物在体内蓄积，使体内酸碱平衡失调，久而久之便呈现酸性体质。
有研究表明，当PH值降低0.1(即体液偏酸)时，胰岛素的活性就下降30％，免疫细胞功能降低，神经的敏感性下降，内分泌及机体许多重要功能将发生紊乱，癌细胞更易生长扩散，红细胞及血小板易发生聚集等。因此，医学专家认为，当今许多慢性病、癌症及亚健康状态都与酸性体质有关。
酸性体质的特征包括：
1、身体出现肥胖、困乏、疲倦及精神不振。
2、酸性体质容易引起溃疡、便秘等。当人体内的酸素升高引起质变，疾病也就产生了。
3、胃酸过多，就会引起胃痛、冒酸水，甚至发展到胃溃疡。
4、体液中的酸性较高，会产生一种酸性物质，医学上称为嘌呤，这种物质在身体内游动，在关节部位会形成一种结晶，这种结晶直接导致关节痛风类疾病。
5、酸性体质会影响孩子的智力。英国牛津大学曾经对42位儿童做过跟踪调查，结果发现孩子的智商与大脑皮层的酸碱度有很大关系。大脑皮层的碱性越强，智商越高。反之则智商越低。
酸性体质的危害
1、强酸与钙、镁等碱性矿物质结合为盐类，即固体酸性物，造成人体骨骼中的钙离子含量降低，从而导致骨质疏松症等疾病。
2、强酸或酸性盐堆积在关节或器官内引起相应炎症，导致动脉硬化、肾结石、关节炎、痛风等疾病。
3、酸性废弃物堆积，使附近的毛细血管被堵，血液循环不畅，导致糖血尿、肾炎及各种癌症。
4、胃肠道酸性过多引起便秘、慢性腹泻、尿酸、四肢酸痛，胃酸过多导致烧心、反酸、胃溃疡等。
另外，根据调查发现，酸性体质的人罹患慢性疾病的机率很高，百分之八十五的痛风、高血压、癌症、高脂血症患者，都是酸性体质。
7.35-7.45这是健康人体的血液PH值范围，这个血液范围PH值的人，抗病能力强，身体健康不易得病。为了人体健康就有必要将酸性体质调理成碱性体质以改善生理状态。
因此，亟需一种能同时调节人体酸碱平衡和阴阳平衡之品，诸药合用共奏平衡人体酸碱度、调节阴阳，提高免疫能力、抗疲劳、改善酸性体质、调理人体亚健康状态，补充人体特别是所需营养物质的功效的固体饮料。
发明内容
本发明的目的是克服现有技术的不足，提供一种魔芋薤白固体饮料。
本发明的第二个目的是提供一种魔芋薤白固体饮料的制备方法。
本发明的技术方案概述如下：
一种魔芋薤白固体饮料的制备方法，包括如下步骤：
(1)按质量称取下述原料：薤白5-10份、桑椹1-3份、山药1-3份和莱菔子2-4份；
(2)分别向各个原料中加入各自原料质量8-10倍的水，煎煮2-5次，每次煎煮1-3小时，滤过，合并滤液，浓缩，分别喷雾干燥成细粉；
(3)将步骤(2)获得的细粉混合后按质量取10份，与魔芋粉3-5份、蛹虫草粉5-10份和大豆蛋白粉5-10份混合得混合粉，加入混合粉质量55％-65％的麦芽糊精，混合均匀，制成颗粒，得到魔芋薤白固体饮料。
步骤(1)优选为按质量称取下述原料：薤白为8份、桑椹为2份、山药为2份、莱菔子为3份。
步骤(3)优选为：将步骤(2)获得的细粉混合后按质量取10份，与魔芋粉4份、蛹虫草粉8份和大豆蛋白粉8份混合得混合粉，加入混合粉质量60％的麦芽糊精，混合均匀，加入体积浓度为70％的食用酒精制成颗粒，得到魔芋薤白固体饮料。
上述方法制备的魔芋薤白固体饮料。
本发明的优点：
1、剂量准确，主药经过提取有效物质剔除了无营养的杂质成分，且经过在辅料中分散均匀，重量差异小，保证了服用人群的服用量。
2、具有疗效迅速，生物利用度高的特点。
3、采用单剂量包装的方式，服用和携带方便。
4、本发明的固体饮料不含糖，扩大了服用人群，糖尿病、肥胖等禁糖人群可以放心服用。
5、本发明的能调节人体酸碱失衡和阴阳失衡等亚健康状态，适用于酸性体质、亚健康、体质虚损，有肿瘤家族病史的人群。
具体实施方式
下面结合具体实施例对本发明作进一步的说明。
实施例1
一种魔芋薤白固体饮料的制备方法，包括如下步骤：
(1)按质量称取下述原料：薤白8份、桑椹2份、山药2份和莱菔子3份；
(2)分别向各个原料中加入各自原料质量9倍的水，煎煮3次，每次煎煮2小时，滤过，合并滤液，浓缩至75℃时相对密度为1.08，分别喷雾干燥成细粉；
(3)将步骤(2)获得的细粉混合后按质量取10份，与魔芋粉4份、蛹虫草粉8份和大豆蛋白粉8份混合得混合粉，加入混合粉质量60％的麦芽糊精，混合均匀，加入体积浓度为70％的食用酒精制成颗粒，为魔芋薤白固体饮料。
实施例2
一种魔芋薤白固体饮料的制备方法，其特征包括如下步骤：
(1)按质量称取下述原料：薤白5份、桑椹3份、山药1份和莱菔子4份；
(2)分别向各个原料中加入各自原料质量8倍的水，煎煮5次，每次煎煮1小时，滤过，合并滤液，浓缩至75℃时相对密度为1.08，分别喷雾干燥成细粉；
(3)将步骤(2)获得的细粉混合后按质量取10份，与魔芋粉3份、蛹虫草粉10份和大豆蛋白粉5份混合得混合粉，加入混合粉质量55％的麦芽糊精，混合均匀，加入体积浓度为70％的食用酒精制成颗粒，得到魔芋薤白固体饮料。
实施例3
一种魔芋薤白固体饮料的制备方法，其特征包括如下步骤：
(1)按质量称取下述原料：薤白10份、桑椹1份、山药3份和莱菔子2份；
(2)分别向各个原料中加入各自原料质量10倍的水，煎煮2次，每次煎煮3小时，滤过，合并滤液，浓缩至75℃时相对密度为1.08，分别喷雾干燥成细粉；
(3)将步骤(2)获得的细粉混合后按质量取10份，与魔芋粉5份、蛹虫草粉5份和大豆蛋白粉10份混合得混合粉，加入混合粉质量65％的麦芽糊精，混合均匀，加入体积浓度为70％的食用酒精制成颗粒，得到魔芋薤白固体饮料。
实施例4
选取具有亚健康状态典型表现，以神疲、失眠多梦人群做临床病例共180例，男130例，女50例：年龄20-56岁，平均36岁。病程6月-3年，随机分为三组:实施例1组、实施例2组和实施例3组，每组60人。
服用方法：
魔芋薤白固体饮料，每袋6克，2次/天，每次2袋，疗程30天，停止使用后随访3月以上统计疗效。
结果：
疗效标准：
显效：症状体征消失，随访3月无复发；
有效：症状体征好转或减轻；
无效：症状体征无明显改变。
治疗结果：
实施例1组，
显效45例(75％)，有效12例(20％),无效3例(5％)，总有效率95％。
实施例2组，
显效43例(72％)，有效12例(20％),无效5例(8％)，总有效率92％。
实施例3组，
显效44例(73％)，有效10例(17％),无效6例(10％)，总有效率90％。
所有病例在治疗过程中未发现毒副作用。
Claims (4)
1.一种魔芋薤白固体饮料的制备方法，其特征包括如下步骤：
(1)按质量称取下述原料：薤白5-10份、桑椹1-3份、山药1-3份和莱菔子2-4份；
(2)分别向各个原料中加入各自原料质量8-10倍的水，煎煮2-5次，每次煎煮1-3小时，滤过，合并滤液，浓缩，分别喷雾干燥成细粉；
(3)将步骤(2)获得的细粉混合后按质量取10份，与魔芋粉3-5份、蛹虫草粉5-10份和大豆蛋白粉5-10份混合得混合粉，加入混合粉质量55％-65％的麦芽糊精，混合均匀，制成颗粒，得到魔芋薤白固体饮料。
2.根据权利要求1所述的方法，其特征是所述薤白为8份、桑椹为2份、山药为2份、莱菔子为3份。
3.根据权利要求1所述的方法，其特征是所述步骤(3)为：将步骤(2)获得的细粉混合后按质量取10份，与魔芋粉4份、蛹虫草粉8份和大豆蛋白粉8份混合得混合粉，加入混合粉质量60％的麦芽糊精，混合均匀，加入体积浓度为70％的食用酒精制成颗粒，得到魔芋薤白固体饮料。
4.权利要求1-3之一的方法制备的魔芋薤白固体饮料。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711496341.2A CN108244442A (zh) | 2017-12-31 | 2017-12-31 | 魔芋薤白固体饮料及制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711496341.2A CN108244442A (zh) | 2017-12-31 | 2017-12-31 | 魔芋薤白固体饮料及制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108244442A true CN108244442A (zh) | 2018-07-06 |
Family
ID=62724584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711496341.2A Pending CN108244442A (zh) | 2017-12-31 | 2017-12-31 | 魔芋薤白固体饮料及制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108244442A (zh) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1556193A (zh) * | 2004-01-10 | 2004-12-22 | 大连轻工业学院 | 用麦芽糖化汁生产食用菌及其保健制品的方法 |
| CN1692831A (zh) * | 2005-05-27 | 2005-11-09 | 程征云 | 一种以藠头为原料的饮料 |
| CN103005592A (zh) * | 2012-12-10 | 2013-04-03 | 亳州市中信食品有限责任公司 | 一种适用于宝宝的固体饮料及其制备方法 |
| CN106913854A (zh) * | 2017-01-22 | 2017-07-04 | 楼良水 | 虫草多糖蛋白肽复合物及其应用 |
| CN107006749A (zh) * | 2017-04-11 | 2017-08-04 | 恩施盛硒源生物科技开发有限公司 | 一种乌发生发且补肾养颜的固体饮料及其制备方法 |
| CN107523457A (zh) * | 2016-06-20 | 2017-12-29 | 莫沉鹏 | 一种魔芋虫草菌丝体饮料酒的生产方法 |
-
2017
- 2017-12-31 CN CN201711496341.2A patent/CN108244442A/zh active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1556193A (zh) * | 2004-01-10 | 2004-12-22 | 大连轻工业学院 | 用麦芽糖化汁生产食用菌及其保健制品的方法 |
| CN1692831A (zh) * | 2005-05-27 | 2005-11-09 | 程征云 | 一种以藠头为原料的饮料 |
| CN103005592A (zh) * | 2012-12-10 | 2013-04-03 | 亳州市中信食品有限责任公司 | 一种适用于宝宝的固体饮料及其制备方法 |
| CN107523457A (zh) * | 2016-06-20 | 2017-12-29 | 莫沉鹏 | 一种魔芋虫草菌丝体饮料酒的生产方法 |
| CN106913854A (zh) * | 2017-01-22 | 2017-07-04 | 楼良水 | 虫草多糖蛋白肽复合物及其应用 |
| CN107006749A (zh) * | 2017-04-11 | 2017-08-04 | 恩施盛硒源生物科技开发有限公司 | 一种乌发生发且补肾养颜的固体饮料及其制备方法 |
Non-Patent Citations (3)
| Title |
|---|
| 史理权: "洋县丘陵地区魔芋高产栽培技术 ", 《农业科技通讯》 * |
| 张占军等: "药食两用植物薤白研究进展 ", 《食品研究与开发》 * |
| 李洪斌: "魔芋虾酥卷配方工艺的优化 ", 《农产品加工(学刊)》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106174585A (zh) | 降血糖的组合物及降血糖的复合益生菌特膳食品 | |
| CN107080265A (zh) | 适用于糖尿病的奇亚籽膳食纤维代餐粉 | |
| CN106912960A (zh) | 一种降血糖保健食品及其制备方法 | |
| CN102919850A (zh) | 一种用于营养食品及药品的组合物 | |
| CN102028139B (zh) | 易吸收钙片 | |
| CN106974291A (zh) | 海参牡蛎肽组合物、其制备方法和制备装置 | |
| CN1820647A (zh) | 一种增强记忆力的营养粉 | |
| CN104905237A (zh) | 桦褐孔菌复合冲剂及其生产方法 | |
| CN109090580A (zh) | 一种用于肿瘤患者的特定全营养配方食品及其制备方法 | |
| CN107048329A (zh) | 一种富锌保健盐及其制备方法 | |
| CN109430664A (zh) | 一种强芯肽固体饮料 | |
| CN108782679A (zh) | 一种减肥干预代餐饼干及其制备方法 | |
| CN107028149A (zh) | 一种富铁保健盐及其制备方法 | |
| CN108244442A (zh) | 魔芋薤白固体饮料及制备方法 | |
| CN109550027A (zh) | 一种改善睡眠质量的口服液的制备方法 | |
| CN103719277A (zh) | 一种加锌奶粉及其生产方法 | |
| CN105495080A (zh) | 一种具有调节血压功能的食品 | |
| CN103798596B (zh) | 一种供心脑血管疾病患者食用的全营养配方食品 | |
| GB2507254A (en) | Composition for reducing the consumption of food and the absorption of carbohydrate constituents thereof | |
| CN105661522A (zh) | 一种对二型糖尿病人平稳血糖进行推荐的方法 | |
| CN101623365B (zh) | 白苓健脾颗粒剂及其制备方法 | |
| CN113349380A (zh) | 一种含牡蛎复合肽肾功能改善剂及其制备方法 | |
| Shakur et al. | Marasmus: An update and review of literature | |
| CN110973326A (zh) | 一种能够改善人体亚健康的压片糖果及其制备方法 | |
| CN108450591A (zh) | 男性保健茶及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180706 |
|
| RJ01 | Rejection of invention patent application after publication |